International Stem Cell (ISCO) 8-K Other Events

Exhibit 99.1

International Stem Cell Corporation and Subsidiaries

Condensed Pro Forma Consolidated Balance Sheet

(in thousands, except share data)

	September 30, 2014			Pro Forma			September 30, 2014
	As Reported			Adjustments			Pro Forma
	(Unaudited)			(Unaudited)			(Unaudited)
Assets
Cash and cash equivalents	$	471		$	—		$	471
Accounts receivable, net of allowance for doubtful accounts of $19		464			—			464
Inventory, net		1,533			—			1,533
Prepaid expenses and other current assets		359			—			359
Restricted cash		50			—			50
Total current assets		2,877			—			2,877
Property and equipment, net		781			—			781
Intangible assets, net		2,649			—			2,649
Deposits and other assets		57			—			57
Total assets	$	6,364		$	—		$	6,364
Liabilities, Redeemable Preferred Stock and Stockholders’ Equity (Deficit)
Accounts payable	$	715		$	—		$	715
Accrued liabilities		1,299			—			1,299
Deferred revenue		—			—			—
Related party payable		5			—			5
Advances		250			—			250
Fair value of warrant liability		—			—			—
Total current liabilities		2,269			—			2,269
Convertible Redeemable Series G Preferred stock, $0.001 par value, 5,000,000 shares authorized, issued and outstanding and liquidation preference of $5,000		4,941			(4,941	)		—
Commitments and contingencies
Stockholders’ Deficit
Series D Preferred stock, $0.001 par value, 50 shares authorized, 43 issued and outstanding with liquidation preference of $4,320		—			—			—
Series B Preferred stock, $0.001 par value, 5,000,000 shares authorized, 300,000 issued and outstanding with liquidation preferences of $417		—			—			—
Common stock, $0.001 par value, 600,000,000 shares authorized, 224,274,073 shares issued and outstanding		224			—			224
Convertible Series G Preferred stock, $0.001 par value, 5,000,000 shares authorized, issued and outstanding, liquidation preference of $5,000		—			4,941			4,941
Additional paid-in capital		89,080			—			89,080
Accumulated deficit		(90,150	)		—			(90,150	)
Total stockholders’ deficit		(846	)		4,941			4,095
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	6,364		$	—		$	6,364